Year archive

Jiangsu Recbio Technology Co., Ltd. — 2023 filings

All 51 regulatory filings released by Jiangsu Recbio Technology Co., Ltd. (2179) in 2023, sourced directly from the official regulator.

51 Filings

2023 Period

2023 filings (51)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT POSITIVE RESULTS IN THE INTERIM ANALYSIS OF THE CLINICAL TRIAL OF THE COMPANY'S NOVEL ADJUVANTED RECOMBINANT SHINGLES VACCINE REC610 IN THE PHILIPPINES Regulatory Filings	2023-12-29	English
ANNOUNCEMENT IN RELATION TO EXTENSION OF VALIDITY PERIOD OF RESOLUTIONS ON ISSUANCE OF DOMESTIC SHARES Capital/Financing Update	2023-12-28	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023 Regulatory Filings	2023-12-01	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023 Regulatory Filings	2023-11-01	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023 Regulatory Filings	2023-10-06	English
2023 Interim Report Interim / Quarterly Report	2023-09-26	English
ARTICLES OF ASSOCIATION Governance Information	2023-09-21	English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING, CLASS MEETING FOR HOLDERS OF DOMESTIC SHARES AND UNLISTED FOREIGN SHARES AND H SHARE CLASS MEETING HELD ON SEPTEMBER 21, 2023 AND AMENDMENTS TO THE A Declaration of Voting Results & Voting Rights Announcements	2023-09-21	English
Form of Proxy for use at the 2023 First H Share Class Meeting to be held on Thursday, September 21, 2023 Proxy Solicitation & Information Statement	2023-09-05	English
Form of Proxy for use at the 2023 First Extraordinary General Meeting to be held on Thursday, September 21, 2023 Proxy Solicitation & Information Statement	2023-09-05	English
NOTICE OF H SHARE CLASS MEETING Proxy Solicitation & Information Statement	2023-09-05	English
NOTICE OF EXTRAORDINARY GENERAL MEETING Regulatory Filings	2023-09-05	English
AMENDMENTS TO THE ARTICLES OF ASSOCIATION, GRANT OF GENERAL MANDATE TO THE BOARD TO ISSUE ADDITIONAL SHARES OF THE COMPANY, NOTICE OF EXTRAORDINARY GENERAL MEETING AND NOTICE OF H SHARE CLASS MEETING Proxy Solicitation & Information Statement	2023-09-05	English
CLOSURE OF REGISTER OF MEMBERS Regulatory Filings	2023-09-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023 Regulatory Filings	2023-09-04	English
ANNOUNCEMENT IN RELATION TO THE AMENDMENTS AND IMPLEMENTATION OF THE 2022 H SHARE INCENTIVE SCHEME OF THE COMPANY Board/Management Information	2023-08-25	English
AMENDMENTS TO THE 2022 H SHARE INCENTIVE SCHEME OF THE COMPANY Board/Management Information	2023-08-25	English
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION Governance Information	2023-08-25	English
UNAUDITED INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023 Interim / Quarterly Report	2023-08-25	English
DATE OF BOARD MEETING Report Publication Announcement	2023-08-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023 Regulatory Filings	2023-08-01	English
VOLUNTARY ANNOUNCEMENT ACCEPTANCE OF CLINICAL TRIAL APPLICATION FOR THE COMPANY'S NOVEL ADJUVANTED RECOMBINANT SHINGLES VACCINE REC610 IN CHINA AND OVERSEAS CLINICAL TRIAL PROGRESS Regulatory Filings	2023-07-26	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023 Regulatory Filings	2023-07-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023 Regulatory Filings	2023-06-01	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2023-05-29	English
VOLUNTARY ANNOUNCEMENT INCLUSION OF THE COMPANY IN THE MSCI CHINA SMALL CAP INDEX Regulatory Filings	2023-05-17	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2023-05-11	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 11, 2023 AND APPOINTMENT OF DIRECTORS Declaration of Voting Results & Voting Rights Announcements	2023-05-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023 Regulatory Filings	2023-05-04	English
INSIDE INFORMATION ANNOUNCEMENT ANNOUNCEMENT IN RELATION TO THE REPLY FROM THE CSRC ON ISSUANCE OF DOMESTIC SHARES Capital/Financing Update	2023-04-19	English
Form of Proxy for use at the 2022 Annual General Meeting to be held on Thursday, May 11, 2023 AGM Information	2023-04-19	English
NOTICE OF 2022 ANNUAL GENERAL MEETING AGM Information	2023-04-19	English
(1) 2022 FINANCIAL ACCOUNTS REPORT (2) 2023 FINANCIAL BUDGET REPORT (3) 2022 WORK REPORT OF THE BOARD OF DIRECTORS (4) 2022 WORK REPORT OF THE SUPERVISORY BOARD (5) 2022 ANNUAL REPORT (6) ENGAGEMENT O AGM Information	2023-04-19	English
2022 Environmental, Social and Governance Report Environmental & Social Information	2023-04-19	English
2022 Annual Report Regulatory Filings	2023-04-19	English
PROPOSED APPOINTMENT OF A DIRECTOR Board/Management Information	2023-04-12	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2023-04-03	English
RESIGNATION OF DIRECTOR Board/Management Information	2023-04-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023 Regulatory Filings	2023-04-03	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022 AND CHANGE IN USE OF PROCEEDS Annual Report	2023-03-20	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2023-03-20	English
CHANGE OF DIRECTORS Board/Management Information	2023-03-20	English
VOLUNTARY ANNOUNCEMENT TWO-COMPONENT RECOMBINANT COVID-19 VACCINE ReCOV GRANTED WITH EMERGENCY USE AUTHORIZATION IN MONGOLIA Regulatory Filings	2023-03-20	English
DATE OF BOARD MEETING Regulatory Filings	2023-03-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023 Regulatory Filings	2023-03-01	English
Next Day Disclosure Return Share Issue/Capital Change	2023-02-20	English
INSIDE INFORMATION ANNOUNCEMENT COMPLETION OF THE H SHARE FULL CIRCULATION Regulatory Filings	2023-02-20	English
VOLUNTARY ANNOUNCEMENT COMPLETION OF THE FIRST BATCH OF SUBJECT ENROLLMENT FOR THE PHASE I CLINICAL TRIAL OF THE COMPANY'S NOVEL ADJUVANTED RECOMBINANT SHINGLES VACCINE REC610 Regulatory Filings	2023-02-13	English
INSIDE INFORMATION ANNOUNCEMENT ANNOUNCEMENT IN RELATION TO THE ACCEPTANCE BY THE CSRC OF THE APPLICATION MATERIALS FOR THE ISSUANCE OF DOMESTIC SHARES Capital/Financing Update	2023-02-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023 Regulatory Filings	2023-02-01	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022 Regulatory Filings	2023-01-03	English